Literature DB >> 3486201

Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities.

C M Brickman, G C Tsokos, T M Chused, J E Balow, T J Lawley, M Santaella, C H Hammer, G F Linton, M M Frank.   

Abstract

Hereditary angioedema is defined biochemically by a deficiency in the functional activity of the inhibitor of Cl, Cl esterase inhibitor (Cl INH). Deficiency of this regulator of the early classic pathway of complement results in chronic activation of this cascade with a resultant deficiency of C4 and C2. Ninety-seven patients with either complicated (associated with autoimmune disorders) or uncomplicated hereditary angioedema were evaluated for laboratory evidence of immunoregulatory defects. Specific cellular and humoral abnormalities were found and included increased mean total lymphocyte counts, increased mean Leu 4+ (total) and Leu 3+ (helper) T cells, an increased mean Leu 3/Leu 2 (helper/suppressor T cell) ratio, polyclonal B cell activation, and evidence of circulating immune complexes. C4 functional titers were negatively correlated with percent Leu 3+ cells and absolute Leu 3+ cell numbers. We failed to detect any evidence of immune deficiency in this population, and yet a statistically significant number of patients demonstrated elevated levels of antibodies to Epstein-Barr virus antigens when patients were compared to a control group. Thus, early classic complement pathway activation and/or partial complement component deficiency may effect T cell subpopulations and B cell activation. However, additional predisposing factors (e.g., genetic or viral) appear necessary for the development of a particular autoimmune disease in hypocomplementemic patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486201     DOI: 10.1016/0091-6749(86)90425-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency.

Authors:  A Kessel; R Peri; R Perricone; M D Guarino; Z Vadasz; R Novak; T Haj; S Kivity; E Toubi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

4.  Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

Authors:  Alberto López-Lera; Fátima Sánchez Cabo; Sofía Garrido; Ana Dopazo; Margarita López-Trascasa
Journal:  Orphanet J Rare Dis       Date:  2013-05-20       Impact factor: 4.123

5.  Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.

Authors:  M Cicardi; T Igarashi; M S Kim; D Frangi; A Agostoni; A E Davis
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 6.  Cutaneous manifestations in celiac disease.

Authors:  L Abenavoli; I Proietti; L Leggio; A Ferrulli; L Vonghia; R Capizzi; M Rotoli; P L Amerio; G Gasbarrini; G Addolorato
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

7.  COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.

Authors:  Camila Lopes Veronez; Sandra C Christiansen; Tukisa D Smith; Marc A Riedl; Bruce L Zuraw
Journal:  Allergy Asthma Proc       Date:  2021-11-01       Impact factor: 2.587

8.  Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report.

Authors:  Yusuke Ushio; Risa Wakiya; Tomohiro Kameda; Shusaku Nakashima; Hiromi Shimada; Mai Mahmoud Fahmy Mansour; Mikiya Kato; Taichi Miyagi; Koichi Sugihara; Rina Mino; Mao Mizusaki; Emi Ibuki; Norimitsu Kadowaki; Hiroaki Dobashi
Journal:  Allergy Asthma Clin Immunol       Date:  2022-09-18       Impact factor: 3.373

9.  Anti-cholesterol antibody levels in hereditary angioedema.

Authors:  Lilian Varga; Adrienn Bíró; Gábor Széplaki; Luca Tóth; Anna Horváth; George Füst; Henriette Farkas
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

10.  Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database.

Authors:  Henriette Farkas; Donald Levy; Dylan Supina; Melvin Berger; Subhransu Prusty; Moshe Fridman
Journal:  Allergy Asthma Clin Immunol       Date:  2020-05-27       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.